Sign inJoin waitlistJoin the waitlist

Susan Rheingold

Professor of Pediatrics, Perelman School of Medicine at the University of Pennsylvania · Children's Hospital of Philadelphia

Credentials: · · ·

History

Children's Hospital of Philadelphia
Present

Pediatric Hematology Oncology
Children's Hospital of Philadelphia
1995–1998
Pediatrics
Johns Hopkins Hospital
1992–1995
The Raymond and Ruth Perelman School of Medicine at the University of Pennsylvania
1988–1992

Research

Chimeric antigen receptor T cells for sustained remissions in leukemia
New England Journal of Medicine · 2014 · 4,445 citations
Chimeric antigen receptor-modified T cells for acute lymphoid leukemia
Case report · New England Journal of Medicine · 2013 · 2,891 citations
Identification of Predictive Biomarkers for Cytokine Release Syndrome after Chimeric Antigen Receptor T-cell Therapy for Acute Lymphoblastic Leukemia
Cancer Discovery · 2016 · 938 citations

Stephan Grupp
25 papers
Richard Aplenc
20 papers
Shannon Maude
19 papers · 1 as a fellow
Deepa Bhojwani
16 papers
Regina Myers
16 papers
Amanda DiNofia
14 papers
Alix Seif
13 papers
Gerald Wertheim
12 papers
David Teachey
11 papers
Allison Leahy
10 papers
Carl June
10 papers
Nirali Shah
10 papers

Clinical trials

Pilot Study of Non-Viral, RNA-Redirected Autologous T Cells in Patients With Refractory or Relapsed Hodgkin Lymphoma
Principal investigator · Terminated · Early phase 1
University of Pennsylvania
2015–2019
Temsirolimus, Dexamethasone, Mitoxantrone Hydrochloride, Vincristine Sulfate, and Pegaspargase in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia or Non-Hodgkin Lymphoma
Principal investigator · Completed · Phase 1
National Cancer Institute (NCI)
2011
Trial of Sirolimus and Methotrexate in Relapsed/Refractory Lymphoblastic Leukemia and Lymphoma
Principal investigator · Completed · Phase 2
Children's Hospital of Philadelphia
2010–2017
A Trial of Temsirolimus With Etoposide and Cyclophosphamide in Children With Relapsed Acute Lymphoblastic Leukemia and Non-Hodgkins Lymphoma
Study chair · Completed · Phase 1
Therapeutic Advances in Childhood Leukemia Consortium
2015–2020